NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
51 hedge funds and large institutions have $9.57M invested in NeuBase Therapeutics, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+1
Holders Change %
+2%
% of All Funds
1.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
11
Closed
7
Calls
$395K
Puts
$984K
Net Calls
-$589K
Net Calls Change
+$345K
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
LTFS
51
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
OM
52
Opaleye Management
Boston,
Massachusetts
| – | -$1.18M | -915 | Closed |
|
53
D.E. Shaw & Co
New York
| – | -$167K | -130 | Closed |
|
|
CS
54
Credit Suisse
Zurich,
Switzerland
| – | -$84K | -65 | Closed |
|
|
VKH
55
Virtu KCG Holdings
New York
| – | -$48K | -38 | Closed |
|
56
Millennium Management
New York
| – | -$33K | -25 | Closed |
|
|
AIM
57
Advantage Investment Management
Cedar Rapids,
Iowa
| – | -$6K | -5 | Closed |
|
58
Wells Fargo
San Francisco,
California
| – | -$1K | -1 | Closed |
|